Discover how the brain "eats" itself during a marathon, and how the recovery process opens doors to possible MS treatments.

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, ...

The first person with multiple sclerosis was imaged in a clinical trial of a PET tracer to track myelin changes.

The disruption of axons—the thread-like part of nerve cells that transmits electrical signals—is associated with Alzheimer's disease. One way axonal function may be hindered is through damage to the ...

The disruption of axons—the thread-like part of nerve cells that transmits electrical signals—is associated with Alzheimer’s disease. One way axonal function may be hindered is through damage to the ...

“Myelin content … is substantially reduced upon marathon running in specific brain regions involved in motor coordination and sensory and emotional integration, but recovers within two months ...

Targeting Myelin Damage in Multiple Sclerosis and Age-Related Decline The drug, LL-341070, enhances the brain's ability to repair damaged myelin— the protective sheath around nerve fibers.

The study was published this week in the journal Nature Communications. The drug, LL-341070, enhances the brain's ability to repair damaged myelin — the protective sheath around nerve fibers.

Causing mice to express more C1QL1, however, led to increased numbers of oligodendrocytes and more myelination upon drug withdrawal, suggesting that C1QL1 helps restore the damaged myelin layer.